Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 52 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 8580927

    Engineered antibody constant domain molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  2. US 8574853

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  3. US 8575375

    Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  4. US 8569028

    Method for encapsulation of microparticles

    The United States of America, as represented by the Secretary of the Agriculture · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  5. US 8568714

    Lys K endolysin is synergistic with lysostaphin against MRSA

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  6. US 8568739

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted

  7. US 8557844

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  8. US 8557788

    Prevention of tissue ischemia and related compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  9. US 8556882

    Inducible interleukin-12

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  10. US 8551936

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted

  11. US 8545888

    Tendon stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  12. US 8546091

    AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  13. US 8546524

    Smoothened polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2013 · Expires Sep 26, 2033

    granted

  14. US 8536148

    Disabling autophagy as a treatment for lysosomal storage diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

    granted

  15. US 8530626

    Methods to produce keratin elastomer

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  16. US 8530167

    Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 10, 2013 · Expires Sep 5, 2033

    granted

  17. US 8524239

    Photosensitizing antibody-fluorophore conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  18. US 8524248

    Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

  19. US 8518957

    Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  20. US 8518968

    Hydrazone and diacyl hydrazine compounds and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  21. US 8512991

    Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  22. US 8506961

    Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (JEV) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  23. US 8501912

    Filipil compositions and methods for treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  24. US 8501688

    SCGB3A2 as a growth factor and anti-apoptotic agent

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.